Cryo-Cell International, Inc.
CCEL
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heartā¦ read more
Healthcare
Medical Care Facilities
32 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$3.42
Price+1.79%
$0.06
1Y
Price
Market Cap
$27.574m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+24.4%
EBITDA Margin+20.7%
Net Profit Margin+31.9%
Free Cash Flow Margin+24.4%
EBITDA Margin+20.7%
Net Profit Margin+31.9%
Free Cash Flow MarginRevenue
$31.128m
-0.7%
1y CAGR+1.5%
3y CAGR+2.4%
5y CAGREarnings
-$2.466m
-0.6%
1y CAGR-113.3%
3y CAGR-76.7%
5y CAGREPS
-$0.29
-240.0%
1y CAGR-193.7%
3y CAGR-137.3%
5y CAGRBook Value
-$17.758m
$60.706m
Assets$78.464m
Liabilities$8.960m
DebtDebt to Assets
14.8%
0.8x
Debt to EBITDAFree Cash Flow
$6.109m
+67.7%
1y CAGR+121.4%
3y CAGR-154.4%
5y CAGRNo items found.
Press Releases
Statements and updates from the company